Hematology/Oncology

Hematology/Oncology 1

Hematology/Oncology 2

120 - From preferences to practice: Clinician-informed strategies to integrate the MyPref values-clarification tool into adolescent and young adult oncology care

135 - Nociceptive Nerves Promote Disease Progression and Metastasis of Osteosarcoma

129 - Oncology Clinicians’ Perspectives Related to Discussing Physical Activity with Adolescent and Young Adults with Cancer: A Qualitative Study

143 - Investigating differential gene expression in clear cell sarcoma of the kidney uncovers potential therapeutic targets

130 - Device-Assessed Sleep Efficiency Among Adolescent and Young Adults (AYA) During Cancer Treatment

144 - Low Bacteremia Rates in Pediatric Febrile Neutropenia at Connecticut Children’s: A Five-Year Review Supporting Outpatient Management

131 - Eltrombopag plus immunosuppressive therapy versus immunosuppressive therapy alone for pediatric severe aplastic anemia: a systematic review and meta-analysis.

145 - CDKN2A Expression Is Associated with Chemoresistance in Ewing Sarcoma

132 - Validation of Mentzer Index for Iron Deficiency Anemia Screening in Pediatrics: A cross sectional study

146 - Spatial Associations of Particulate Matter (PM2.5) and Childhood Cancer in Massachusetts

133 - 2-Year Crovalimab Paroxysmal Nocturnal Haemoglobinuria (PNH) Data for Fatigue, a Relevant Symptom in Atypical Haemolytic Uraemic Syndrome (aHUS) and PNH

147 - Single-center experience of pediatric post-hematopoietic stem cell transplant patients with sinusoidal obstructive syndrome requiring continuous renal replacement therapy: A retrospective study.

134 - Identifying Barriers to Discharge Readiness for At-Risk Children with Cancer: A Mixed-methods Study

148 - Evaluating the burden of dyslipidemia in childhood cancer survivors and developing a protocol for screening, detection, and management

121 - Acute Chest Syndrome (ACS) in Children and Adolescents Hospitalized for Sickle Cell Disease (SCD) Vaso-occlusive Pain Episodes (VOE)

122 - Improvement of Sickle Cell Disease Care Mitigates the Healthcare Utilization Induced by Increased Prevalence: Experience of a Tertiary Pediatric Center

137 - Zika Virus as an Oncolytic Treatment for Rhabdomyosarcoma

123 - Efficacy and Safety of Eltrombopag for Treatment of Pediatric Immune Thrombocytopenia: A Systematic Review and Meta-analysis

138 - The Oncolytic Activity of Zika Viral Therapy in Human Hepatoblastoma Occurs in a CD24 Dependent Manner

124 - KAT14 as a Novel Gene Associated with Diamond-Blackfan Anemia

139 - Zika Virus as an Oncolytic Treatment for Diffuse Intrinsic Pontine Glioma (DIPG)

125 - National Alliance of Sickle Cell Centers 2025 Consensus on Management of Acute Pain Crisis for Children and Adults with Sickle Cell Disease

140 - Efficacy of digital PCR for the determination of NUDT15 diplotype in patients with pediatric acute lymphoblastic leukemia

126 - Biopsychosocial Predictors of Gastrointestinal Late Effects among Adolescent and Young Adult Survivors of Childhood Cancer

127 - From Advisors to Investigators: A Community-Led Study to Address Provider Stigma in Sickle Cell Disease

141 - Efficacy of fluoroquinolone prophylaxis during induction phase in children with acute lymphoblastic leukemia: a systematic review and meta-analysis

128 - Pain Outcomes in Children with Sickle Cell Disease Reported via Texting following Emergency Department Discharge for Acute Pain Events

142 - Upper Gastrointestinal Bleeding Among Children With Acute Lymphoblastic Leukemia; Did the Outcomes Differ Between Males and Females?